• Product NameClarithromycin
• Brief DescriptionInhibitors
• Purification99.89%
• Biological ActivityClarithromycin is a macrolide antibiotic and a CYP3A4 inhibitor.
• Target NameMRP inhibitor; ribosome inhibitor
• CAS No. 81103-11-9
• Calculated MW 747.95
• Formulation C38H69NO13
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Immunology
  SMILES:CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
  Pathways:Immunology/Inflammation; Microbiology&virology
  Receptor:MRP1; 50S ribosome
  Boling pt:805.5C
  Melting pt:217-220C
  Solubility:DMSO: 5 mg/mL (6.68 mM)
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Flockhart DA. . Indiana University School of Medicine (2007). Accessed May 28, 2010.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting